US Patent 10377750 5-methyl-1,3,4-oxadiazol-2-yl compounds
Patent 10377750 was granted and assigned to Eli Lilly and Company on August, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 18, 2018
0
Date of Patent
August 13, 2019
0
Patent Applicant
Patent Application Number
15983269
0
Patent Citations
Patent Citations Received
Patent Inventor Names
Nicolas Jacques Francois Dreyfus
0
Peter James Lindsay-Scott
0
Richard Edmund Rathmell
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10377750 5-methyl-1,3,4-oxadiazol-2-yl compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
